Jasper Therapeutics (JSPR) Non Operating Income (2023 - 2025)
Jasper Therapeutics (JSPR) posted quarterly Non Operating Income of $6.7 million for Q4 2025, up 598.96% year-over-year from $964000.0 in Q4 2024, and up 1466.98% quarter-over-quarter from $430000.0 in Q3 2025.
Jasper Therapeutics (JSPR) Non Operating Income (2023 - 2025) Analysis & Trends
Jasper Therapeutics' Non Operating Income history runs 3 years deep, the most recent figure standing at $6.7 million for Q4 2025.
- In Q4 2025, Non Operating Income rose 598.96% year-over-year to $6.7 million; the TTM figure through Dec 2025 stood at $8.1 million (up 62.62% YoY), while the FY2025 annual figure was $8.1 million, up 62.62% from the prior year.
- Non Operating Income for Q4 2025 stood at $6.7 million, up from $430000.0 in the prior quarter.
- The five-year high for Non Operating Income was $6.7 million in Q4 2025, with the low at -$313000.0 in Q1 2023.
- The 3-year median for Non Operating Income is $1.2 million (2023), against an average of $1.5 million.
- Peak annual rise in Non Operating Income reached 598.96% in 2025, while the deepest fall reached 74.96% in 2025.
- Jasper Therapeutics' Non Operating Income stood at $1.1 million in 2023, then fell by 15.73% to $964000.0 in 2024, then soared by 598.96% to $6.7 million in 2025.
- Business Quant data shows JSPR's Non Operating Income at $6.7 million in Q4 2025, $430000.0 in Q3 2025, and $353000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.52 Bn | 132.67 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.55 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 65.31 Bn | 60.13 Bn | 1.37 Bn | - |
| 4 | Moderna | 61.77 Bn | 56.64 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.26 Bn | 37.16 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.19 Bn | 27.88 Bn | 992.69 Mn | -53.64 Mn |
| 7 | BioNTech SE | 28.71 Bn | 10.31 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.35 Bn | 26.52 Bn | - | -51.63 Mn |
| 10 | Jasper Therapeutics | 20.38 Mn | 20.38 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.74 Mn |
| Sep 30, 2025 | 430,000.00 |
| Jun 30, 2025 | 353,000.00 |
| Mar 31, 2025 | 561,000.00 |
| Dec 31, 2024 | 964,000.00 |
| Sep 30, 2024 | 1.25 Mn |
| Jun 30, 2024 | 1.41 Mn |
| Mar 31, 2024 | 1.34 Mn |
| Dec 31, 2023 | 1.14 Mn |
| Sep 30, 2023 | 1.82 Mn |
| Jun 30, 2023 | 1.75 Mn |
| Mar 31, 2023 | -313,000.00 |